Study links high-fat cheese to lower dementia risk

A Swedish study suggests that consuming more high-fat cheese could lower dementia risk by 13%, based on data from nearly 30,000 people followed for 25 years. However, experts caution that it is an observational analysis without proof of causality. Critics highlight potential confounders and the importance of factors like blood pressure and weight control.

A new study published in the journal Neurology analyzes data from 27,670 people in Sweden, with an average age of 58 at the start. Participants recorded their diet for a week and were followed for 25 years, during which 3,208 developed dementia. After adjusting for variables like age, sex, education, and overall diet quality, researchers found that those consuming more cheese with over 20% fat—such as manchego, parmesan, roquefort, or cheddar—had a 13% lower risk of dementia compared to those consuming less.

Emily Sonestedt, epidemiologist at Lund University and lead author, stated: “For decades, the debate on high-fat versus low-fat diets has shaped health advice, even categorizing cheese as an unhealthy food to limit. Our study discovered that some high-fat dairy products may actually reduce dementia risk, challenging entrenched assumptions about brain health”.

However, experts like Naveed Sattar from the University of Glasgow criticize the study for not proving causality and for potential confounders, such as higher education levels among cheese consumers. “We already know several well-established and proven factors that reduce dementia risk, like maintaining healthy blood pressure, controlling weight, and preventing heart disease or strokes. These interventions should remain the priority,” Sattar asserts.

Tara Spires-Jones from the University of Edinburgh adds that diets change over time and there is no solid evidence that a specific food protects against dementia. Dementia affected 57 million people in 2019 and could reach 153 million by 2050. A Lancet Commission report indicates that 45% of cases could be prevented by eliminating 14 risks, including excess LDL cholesterol, which accounts for 7% and is linked to strokes and Alzheimer's proteins. A meta-analysis from Peking University associates saturated fats with greater cognitive decline, though with methodological caution.

Experts stress that most dementia factors, like age and genetics, are beyond individual control, and there is no causal evidence of prevention through diet.

संबंधित लेख

Split-image illustration contrasting healthy (whole grains, plants, unsaturated fats) vs. unhealthy (refined carbs, animal fats) low-carb and low-fat diets, highlighting heart disease risk reduction from food quality per recent study.
AI द्वारा उत्पन्न छवि

Study links heart benefits of low-carb and low-fat diets to food quality, not macronutrient cuts

AI द्वारा रिपोर्ट किया गया AI द्वारा उत्पन्न छवि तथ्य-जाँच किया गया

A long-running analysis of nearly 200,000 U.S. health professionals found that both low-carbohydrate and low-fat eating patterns were associated with lower coronary heart disease risk when they emphasized high-quality foods such as whole grains, plant-based sources, and unsaturated fats. Versions of these diets built around refined carbohydrates and animal-based fats and proteins were associated with higher risk, according to a study published in the Journal of the American College of Cardiology (JACC).

Older adults carrying high-risk APOE4 gene variants experienced slower cognitive decline and lower dementia risk with higher meat consumption, according to a Karolinska Institutet study of over 2,100 participants tracked for up to 15 years. Findings suggest diet's effects on brain health vary by genetics, challenging one-size-fits-all advice.

AI द्वारा रिपोर्ट किया गया

Adults age 65 and older who consume eggs regularly face a reduced chance of developing Alzheimer’s disease, according to new research from Loma Linda University Health. The study found that eating at least five eggs per week was associated with up to a 27 percent lower risk. Even modest intake showed measurable benefits.

A team of researchers led by Professor Yan-Jiang Wang has published a review arguing that Alzheimer's disease requires integrated treatments targeting multiple factors, not single causes. New drugs like lecanemab and donanemab offer modest benefits by slowing decline, but fall short of reversal. The paper, in Science China Life Sciences, emphasizes genetics, aging, and systemic health alongside amyloid-beta and tau proteins.

AI द्वारा रिपोर्ट किया गया

A large European study of over 10,000 older adults found that those reporting higher loneliness had poorer initial memory performance but experienced memory decline at the same rate as less lonely peers. The research, based on seven years of data, challenges notions that loneliness accelerates cognitive deterioration. Researchers recommend screening for loneliness in cognitive health assessments.

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए विश्लेषण के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें